Green Bioactives raised £2.6M in Seed financing led by Eos Advisory LLP, with participation from Regenerate Ventures’ Agtech Fund, Milltrust International Group, and Scottish Enterprise. Andrew Durkie, Partner at Eos, will join the company's board. The company plans to use the funds to expand its management, production, and research teams and to demonstrate its biomanufacturing approach at larger scale. Green Bioactives leverages plant vascular stem cells to build a platform for sustainable biomanufacturing of plant biomolecules for commercial applications in cosmetics, pharmaceuticals, food, and agricultural industries. Its capabilities span initial isolation of bioactive-producing plant cells through to supply of the final purified product, aiming to provide improved and sustainable access to the diverse library of plant bioactives. Founded in 2020 and based at the Roslin Innovation Centre in Edinburgh, the company is working with several world-leading partners—including a multinational consumer goods company, a multinational biotechnology company, and a global agricultural solutions company—to produce high-value bioactives that cannot be readily produced sustainably or economically using alternative approaches.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2022